A novel plant transformation approach that uses Agrobacterium-mediated floral inoculation to produce transgenic cotton plants, offering a simpler alternative to traditional tissue culture methods. Preliminary results demonstrate feasibility, with optimization poised to enable high-throughput cotton transformation and genome editing.
This research explores a novel method for producing transgenic cotton plants by directly inoculating flowers with Agrobacterium carrying transgene constructs. Traditional cotton transformation relies on labor-intensive tissue culture techniques, which are costly and time-consuming. Floral inoculation offers a simpler, potentially high-throughput alternative that could significantly reduce the time, cost, and infrastructure required to generate transgenic cotton lines. Preliminary laboratory results confirm that transgenic cotton plants can be recovered using this method, establishing a foundation for further optimization and broader application in cotton biotechnology and genome editing.
Key features:
Observed performance:
This technology is at an early research and development stage (TRL 3-4). Proof-of-concept has been demonstrated with successful recovery of transgenic cotton plants from florally inoculated flowers. Current efforts are focused on optimizing the procedure by evaluating variations in inoculation method, timing, inoculum composition, and selection strategies. Future validation will include characterization of T-DNA insertion number, position, and the presence of adventitious insertions in recovered T2 plants. The method is not yet commercially ready but represents a promising pathway toward simplifying cotton transformation for research and breeding applications.
Oklahoma State University is a comprehensive public land‑grant research university with a statewide footprint anchored in Stillwater. A research and technology park connects faculty expertise with corporate partners through co‑located labs, flexible leases, and shared prototyping and pilot‑scale facilities. Integration with an academic health system in Tulsa and a veterinary teaching hospital supports clinical translation, field trials, and product evaluation. A statewide extension network and experiment stations provide industry with rapid access to real‑world testing sites and workforce pipelines. Research is supported by competitive federal funding from NSF, USDA, NIH, and DOE, alongside industry‑sponsored agreements. A dedicated technology transfer office and an affiliated incubator accelerate IP protection, licensing, and startup formation.